A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients (Q43251106)
Jump to navigation
Jump to search
scientific article published on 30 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients |
scientific article published on 30 October 2009 |
Statements
1 reference
A randomized, placebo-controlled study of the effects of the p38 MAPK inhibitor SB-681323 on blood biomarkers of inflammation in COPD patients (English)
1 reference
Ruth Tal-Singer
1 reference
Dave Singh
1 reference
Lucy Smyth
1 reference
Zoe Borrill
1 reference
Lisa Sweeney
1 reference
30 October 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference